These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32711186)

  • 1. MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival.
    Casanova NG; Zhou T; Gonzalez-Garay ML; Lussier YA; Sweiss N; Ma SF; Noth I; Knox KS; Garcia JGN
    Transl Res; 2021 Feb; 228():1-12. PubMed ID: 32711186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
    Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
    Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.
    Herazo-Maya JD; Noth I; Duncan SR; Kim S; Ma SF; Tseng GC; Feingold E; Juan-Guardela BM; Richards TJ; Lussier Y; Huang Y; Vij R; Lindell KO; Xue J; Gibson KF; Shapiro SD; Garcia JG; Kaminski N
    Sci Transl Med; 2013 Oct; 5(205):205ra136. PubMed ID: 24089408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for airways biomarkers useful to identify progressive pulmonary fibrosis.
    Soccio P; Moriondo G; Scioscia G; Leo V; Tondo P; Salerno L; Palange P; Barbaro MPF; Lacedonia D
    BMC Pulm Med; 2023 Oct; 23(1):407. PubMed ID: 37884953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
    Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
    BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis.
    Yang IV; Luna LG; Cotter J; Talbert J; Leach SM; Kidd R; Turner J; Kummer N; Kervitsky D; Brown KK; Boon K; Schwarz MI; Schwartz DA; Steele MP
    PLoS One; 2012; 7(6):e37708. PubMed ID: 22761659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.
    Herazo-Maya JD; Sun J; Molyneaux PL; Li Q; Villalba JA; Tzouvelekis A; Lynn H; Juan-Guardela BM; Risquez C; Osorio JC; Yan X; Michel G; Aurelien N; Lindell KO; Klesen MJ; Moffatt MF; Cookson WO; Zhang Y; Garcia JGN; Noth I; Prasse A; Bar-Joseph Z; Gibson KF; Zhao H; Herzog EL; Rosas IO; Maher TM; Kaminski N
    Lancet Respir Med; 2017 Nov; 5(11):857-868. PubMed ID: 28942086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.
    Meltzer EB; Barry WT; D'Amico TA; Davis RD; Lin SS; Onaitis MW; Morrison LD; Sporn TA; Steele MP; Noble PW
    BMC Med Genomics; 2011 Oct; 4():70. PubMed ID: 21974901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-Approaching with Next-Generation Sequencing and Bioinformatics.
    Chang WA; Chen CM; Sheu CC; Liao SH; Hsu YL; Tsai MJ; Kuo PL
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis.
    Zhou M; Ouyang J; Zhang G; Zhu X
    BMC Pulm Med; 2022 Dec; 22(1):467. PubMed ID: 36474231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
    Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
    BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel AT2 Cell Subpopulations and Diagnostic Biomarkers in IPF: Integrating Machine Learning with Single-Cell Analysis.
    Yang Z; Yang Y; Han X; Hou J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis.
    Huang G; Xu X; Ju C; Zhong N; He J; Tang XX
    Front Immunol; 2022; 13():997138. PubMed ID: 36211385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis.
    Njock MS; Guiot J; Henket MA; Nivelles O; Thiry M; Dequiedt F; Corhay JL; Louis RE; Struman I
    Thorax; 2019 Mar; 74(3):309-312. PubMed ID: 30244194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis.
    Di Mauro S; Scamporrino A; Fruciano M; Filippello A; Fagone E; Gili E; Scionti F; Purrazzo G; Di Pino A; Scicali R; Di Martino MT; Malaguarnera R; Malatino L; Purrello F; Vancheri C; Piro S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.